These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 22968431)

  • 1. Limited contribution of common genetic variants to risk for liver injury due to a variety of drugs.
    Urban TJ; Shen Y; Stolz A; Chalasani N; Fontana RJ; Rochon J; Ge D; Shianna KV; Daly AK; Lucena MI; Nelson MR; Molokhia M; Aithal GP; Floratos A; Pe'er I; Serrano J; Bonkovsky H; Davern TJ; Lee WM; Navarro VJ; Talwalkar JA; Goldstein DB; Watkins PB; ; ; ; ;
    Pharmacogenet Genomics; 2012 Nov; 22(11):784-95. PubMed ID: 22968431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study.
    Nicoletti P; Aithal GP; Bjornsson ES; Andrade RJ; Sawle A; Arrese M; Barnhart HX; Bondon-Guitton E; Hayashi PH; Bessone F; Carvajal A; Cascorbi I; Cirulli ET; Chalasani N; Conforti A; Coulthard SA; Daly MJ; Day CP; Dillon JF; Fontana RJ; Grove JI; Hallberg P; Hernández N; Ibáñez L; Kullak-Ublick GA; Laitinen T; Larrey D; Lucena MI; Maitland-van der Zee AH; Martin JH; Molokhia M; Pirmohamed M; Powell EE; Qin S; Serrano J; Stephens C; Stolz A; Wadelius M; Watkins PB; Floratos A; Shen Y; Nelson MR; Urban TJ; Daly AK;
    Gastroenterology; 2017 Apr; 152(5):1078-1089. PubMed ID: 28043905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles.
    Lucena MI; Molokhia M; Shen Y; Urban TJ; Aithal GP; Andrade RJ; Day CP; Ruiz-Cabello F; Donaldson PT; Stephens C; Pirmohamed M; Romero-Gomez M; Navarro JM; Fontana RJ; Miller M; Groome M; Bondon-Guitton E; Conforti A; Stricker BH; Carvajal A; Ibanez L; Yue QY; Eichelbaum M; Floratos A; Pe'er I; Daly MJ; Goldstein DB; Dillon JF; Nelson MR; Watkins PB; Daly AK; ; ; ; ;
    Gastroenterology; 2011 Jul; 141(1):338-47. PubMed ID: 21570397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Missense Variant in PTPN22 is a Risk Factor for Drug-induced Liver Injury.
    Cirulli ET; Nicoletti P; Abramson K; Andrade RJ; Bjornsson ES; Chalasani N; Fontana RJ; Hallberg P; Li YJ; Lucena MI; Long N; Molokhia M; Nelson MR; Odin JA; Pirmohamed M; Rafnar T; Serrano J; Stefánsson K; Stolz A; Daly AK; Aithal GP; Watkins PB; ;
    Gastroenterology; 2019 May; 156(6):1707-1716.e2. PubMed ID: 30664875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Reduced ERAP2 Expression and a Novel HLA Allele as Components of a Risk Score for Susceptibility to Liver Injury Due to Amoxicillin-Clavulanate.
    Nicoletti P; Dellinger A; Li YJ; Barnhart HX; Chalasani N; Fontana RJ; Odin JA; Serrano J; Stolz A; Etheridge AS; Innocenti F; Govaere O; Grove JI; Stephens C; Aithal GP; Andrade RJ; Bjornsson ES; Daly AK; Lucena MI; Watkins PB; ; ;
    Gastroenterology; 2023 Mar; 164(3):454-466. PubMed ID: 36496055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-induced liver injury: past, present and future.
    Daly AK
    Pharmacogenomics; 2010 May; 11(5):607-11. PubMed ID: 20415545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association study of UGT1A9 promoter polymorphisms with DILI based on systematically regional variation screen in Chinese population.
    Jiang J; Zhang X; Huo R; Li X; Yang Y; Gai Z; Xu M; Shen L; Cai L; Wan C; Li B; He L; Qin S
    Pharmacogenomics J; 2015 Aug; 15(4):326-31. PubMed ID: 25446781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minocycline hepatotoxicity: Clinical characterization and identification of HLA-B∗35:02 as a risk factor.
    Urban TJ; Nicoletti P; Chalasani N; Serrano J; Stolz A; Daly AK; Aithal GP; Dillon J; Navarro V; Odin J; Barnhart H; Ostrov D; Long N; Cirulli ET; Watkins PB; Fontana RJ; ; ;
    J Hepatol; 2017 Jul; 67(1):137-144. PubMed ID: 28323125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-Induced Liver Injury due to Flucloxacillin: Relevance of Multiple Human Leukocyte Antigen Alleles.
    Nicoletti P; Aithal GP; Chamberlain TC; Coulthard S; Alshabeeb M; Grove JI; Andrade RJ; Bjornsson E; Dillon JF; Hallberg P; Lucena MI; Maitland-van der Zee AH; Martin JH; Molokhia M; Pirmohamed M; Wadelius M; Shen Y; Nelson MR; Daly AK;
    Clin Pharmacol Ther; 2019 Jul; 106(1):245-253. PubMed ID: 30661239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of Oxidative Stress-Related Candidate Genes as Risk Factors for Drug-Induced Liver Injury due to Co-Amoxiclav.
    Alshabeeb MA; Aithal GP; Daly AK
    DNA Cell Biol; 2020 Mar; 39(3):349-354. PubMed ID: 31905014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic polymorphisms of CYP2C9 and CYP2C19 are not related to drug-induced idiosyncratic liver injury (DILI).
    Pachkoria K; Lucena MI; Ruiz-Cabello F; Crespo E; Cabello MR; Andrade RJ;
    Br J Pharmacol; 2007 Mar; 150(6):808-15. PubMed ID: 17279092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis of idiosyncratic drug-induced liver injury and clinical perspectives.
    Fontana RJ
    Gastroenterology; 2014 Apr; 146(4):914-28. PubMed ID: 24389305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-DRB1*16: 01-DQB1*05: 02 is a novel genetic risk factor for flupirtine-induced liver injury.
    Nicoletti P; Werk AN; Sawle A; Shen Y; Urban TJ; Coulthard SA; Bjornsson ES; Cascorbi I; Floratos A; Stammschulte T; Gundert-Remy U; Nelson MR; Aithal GP; Daly AK;
    Pharmacogenet Genomics; 2016 May; 26(5):218-24. PubMed ID: 26959717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA alleles influence the clinical signature of amoxicillin-clavulanate hepatotoxicity.
    Stephens C; López-Nevot MÁ; Ruiz-Cabello F; Ulzurrun E; Soriano G; Romero-Gómez M; Moreno-Casares A; Lucena MI; Andrade RJ
    PLoS One; 2013; 8(7):e68111. PubMed ID: 23874514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amoxicillin-Clavulanate-Induced Liver Injury.
    deLemos AS; Ghabril M; Rockey DC; Gu J; Barnhart HX; Fontana RJ; Kleiner DE; Bonkovsky HL;
    Dig Dis Sci; 2016 Aug; 61(8):2406-2416. PubMed ID: 27003146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic risk factors in the development of idiosyncratic drug-induced liver injury.
    Stephens C; Lucena MI; Andrade RJ
    Expert Opin Drug Metab Toxicol; 2021 Feb; 17(2):153-169. PubMed ID: 33222552
    [No Abstract]   [Full Text] [Related]  

  • 17. HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin.
    Daly AK; Donaldson PT; Bhatnagar P; Shen Y; Pe'er I; Floratos A; Daly MJ; Goldstein DB; John S; Nelson MR; Graham J; Park BK; Dillon JF; Bernal W; Cordell HJ; Pirmohamed M; Aithal GP; Day CP; ;
    Nat Genet; 2009 Jul; 41(7):816-9. PubMed ID: 19483685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide Association Study of Methotrexate-Induced Liver Injury in Rheumatoid Arthritis Patients.
    Eektimmerman F; Swen JJ; den Broeder AA; Hazes JMW; Kurreeman FS; Verstappen SMM; Nair N; Pawlik A; Nurmohamed MT; Dolžan V; Böhringer S; Allaart CF; Guchelaar HJ
    Clin Pharmacol Ther; 2023 Apr; 113(4):916-923. PubMed ID: 36708065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human leukocyte antigen genetic risk factors of drug-induced liver toxicology.
    Grove JI; Aithal GP
    Expert Opin Drug Metab Toxicol; 2015 Mar; 11(3):395-409. PubMed ID: 25491399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetic testing in idiosyncratic drug-induced liver injury: current role in clinical practice.
    Aithal GP
    Liver Int; 2015 Jul; 35(7):1801-8. PubMed ID: 25809692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.